T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics

‘Targeted’ or ‘biological’ cancer treatments rely on differential gene expression between normal tissue and cancer, and genetic changes that render tumour cells especially sensitive to the agent being applied. Problems exist with the application of many agents as a result of damage to local tissues,...

Descripción completa

Detalles Bibliográficos
Autores principales: Herbert, Katharine J., Ashton, Thomas M., Prevo, Remko, Pirovano, Giacomo, Higgins, Geoff S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200809/
https://www.ncbi.nlm.nih.gov/pubmed/30356039
http://dx.doi.org/10.1038/s41419-018-1131-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200809/
https://www.ncbi.nlm.nih.gov/pubmed/30356039
http://dx.doi.org/10.1038/s41419-018-1131-7

Ejemplares similares